MAPT and cancer: Our data, showing an overexpression of Tau in cancer cell lines and tissues with little or no CDA, highlight the importance of analyzing CDA and Tau expression levels simultaneously in cancer tissues, as a relevant and predictive marker of susceptibility to anti-cancer therapies.